NFG
RVLP

Nations Financial Group’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Nations Financial Group’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,500
Closed -$37K – 491
2021
Q3 		$37K Buy
+12,500
New +$42K 0.01% 433

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nations Financial Group's RVLP Position: Q4 2021 in Review

Nations Financial Group sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2021, closing a stake of 12,500 shares — an estimated $37K sold.

Nations Financial Group first reported a position in RVLP in Q3 2021 and held it in 1 quarter. The position peaked at $37K in Q3 2021. 31 funds tracked by Wall St. Rank hold RVLP as of Q4 2021.

  • Nations Financial Group reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Nations Financial Group sold 12,500 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2021, an estimated $37K.
  • Nations Financial Group first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q3 2021 and held it in 1 quarter.
  • Nations Financial Group's RVL Pharmaceuticals plc Ordinary Shares position peaked at $37K in Q3 2021.
  • 31 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2021.

Based on Nations Financial Group's 13F filing for Q4 2021, filed 10 Feb 2022.